Xtant Losses Continue in 2Q19 on Lumbar Implant Recall

• Sales decline primarily due to December 2018 recall of the PLX lumbar spine implant and termination of advisory agreement with a company that provided services to some Xtant customers
• Continuing to cut costs by streamlining manufacturing operations and the sales channel
• Hired additional sales personnel during the first half to bolster revenue stream

Performance by Segment

ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM):

Sales by Geographic Region

ORTHOWORLD estimates geographic sales and growth as follows ($MM):

Net Earnings Data

Net earnings, inclusive of all revenue, are as follows.

Sources: Xtant; ORTHOWORLD estimates.

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.